BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 7692998)

  • 1. The glutamate decarboxylase and 38KD autoantigens in type 1 diabetes: aspects of structure and epitope recognition.
    Baekkeskov S; Aanstoot HJ; Fu Q; Jaffe M; Kim J; Quan J; Richter W; Shi Y
    Autoimmunity; 1993; 15 Suppl():24-6. PubMed ID: 7692998
    [No Abstract]   [Full Text] [Related]  

  • 2. Characterization of distinct islet protein autoantigens associated with type 1 diabetes.
    Christie MR
    Autoimmunity; 1993; 15 Suppl():1-3. PubMed ID: 8218841
    [No Abstract]   [Full Text] [Related]  

  • 3. Hyperexpression of GAD in the islets may be relevant but is it sufficient to induce autoimmune insulitis?
    Pozzilli P; Leslie RD
    Diabetologia; 1997 Mar; 40(3):357-61. PubMed ID: 9084978
    [No Abstract]   [Full Text] [Related]  

  • 4. Islet cell antigens in insulin-dependent diabetes: Pandora's box revisited.
    Harrison LC
    Immunol Today; 1992 Sep; 13(9):348-52. PubMed ID: 1466752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytoplasmic islet cell antibodies (ICA): towards a molecular understanding of the autoantigens.
    Scherbaum WA
    Clin Endocrinol (Oxf); 1994 Jan; 40(1):15-8. PubMed ID: 7508344
    [No Abstract]   [Full Text] [Related]  

  • 6. Contribution of glutamate decarboxylase antibodies to the reactivity of islet cell cytoplasmic antibodies.
    Marshall MO; Høyer PE; Petersen JS; Hejnaes KR; Genovese S; Dyrberg T; Bottazzo GF
    J Autoimmun; 1994 Aug; 7(4):497-508. PubMed ID: 7980851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intermolecular antigen spreading occurs during the preclinical period of human type 1 diabetes.
    Brooks-Worrell B; Gersuk VH; Greenbaum C; Palmer JP
    J Immunol; 2001 Apr; 166(8):5265-70. PubMed ID: 11290812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Autoantibodies in type 1 diabetes mellitus].
    Ziegler M; Ziegler B
    Z Arztl Fortbild (Jena); 1994 Aug; 88(7-8):561-5. PubMed ID: 7856261
    [No Abstract]   [Full Text] [Related]  

  • 9. Conversations with GAD.
    Nepom GT
    J Autoimmun; 2003 May; 20(3):195-8. PubMed ID: 12753802
    [No Abstract]   [Full Text] [Related]  

  • 10. Glutamic acid decarboxylase autoantibodies in stiff-man syndrome and insulin-dependent diabetes mellitus exhibit similarities and differences in epitope recognition.
    Daw K; Ujihara N; Atkinson M; Powers AC
    J Immunol; 1996 Jan; 156(2):818-25. PubMed ID: 8543838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoantibodies against a novel 51 kDa islet antigen and glutamate decarboxylase isoforms in autoimmune polyendocrine syndrome type I.
    Velloso LA; Winqvist O; Gustafsson J; Kämpe O; Karlsson FA
    Diabetologia; 1994 Jan; 37(1):61-9. PubMed ID: 8150232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoglobulin gene usage in diabetes-associated human monoclonal antibodies recognizing glutamate decarboxylase.
    Richter W; Jury KM; Loeffler D; Eiermann TH; Boehm BO
    Ann N Y Acad Sci; 1995 Sep; 764():457-60. PubMed ID: 7486565
    [No Abstract]   [Full Text] [Related]  

  • 13. Sequence similarity between beta-cell autoantigens.
    Rudy G; Brusic V; Harrison LC; Lew AM
    Immunol Today; 1995 Aug; 16(8):406-7. PubMed ID: 7546199
    [No Abstract]   [Full Text] [Related]  

  • 14. Autoantigens in type 1 diabetes mellitus.
    Dotta F; Anastasi E; Tiberti C; Di Mario U
    J Endocrinol Invest; 1994; 17(7):497-508. PubMed ID: 7829824
    [No Abstract]   [Full Text] [Related]  

  • 15. GAD, a single autoantigen for diabetes.
    von Boehmer H; Sarukhan A
    Science; 1999 May; 284(5417):1135, 1137. PubMed ID: 10366347
    [No Abstract]   [Full Text] [Related]  

  • 16. Early development and spreading of autoantibodies to epitopes of IA-2 and their association with progression to type 1 diabetes.
    Naserke HE; Ziegler AG; Lampasona V; Bonifacio E
    J Immunol; 1998 Dec; 161(12):6963-9. PubMed ID: 9862731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoimmunity to two forms of glutamate decarboxylase in insulin-dependent diabetes mellitus.
    Kaufman DL; Erlander MG; Clare-Salzler M; Atkinson MA; Maclaren NK; Tobin AJ
    J Clin Invest; 1992 Jan; 89(1):283-92. PubMed ID: 1370298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential islet cell expression of two glutamate decarboxylases, both autoantigens in diabetes.
    Michelsen BK; Petersen JS; Rambrandt TB; Boel E; Karlsen AE; Videbaek N; Blume N; Madsen OD
    Biochem Soc Trans; 1993 Feb; 21(1):173-7. PubMed ID: 8449288
    [No Abstract]   [Full Text] [Related]  

  • 19. It's insulin.
    Wegmann DR; Eisenbarth GS
    J Autoimmun; 2000 Nov; 15(3):286-91. PubMed ID: 11040069
    [No Abstract]   [Full Text] [Related]  

  • 20. Cellular and molecular pathogenic mechanisms of insulin-dependent diabetes mellitus.
    Yoon JW; Jun HS
    Ann N Y Acad Sci; 2001 Apr; 928():200-11. PubMed ID: 11795511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.